CCL

Összesen 5 találat.
#/oldal:
Részletezés:
Rendezés:

1.

001-es BibID:BIBFORM101421
035-os BibID:(cikkazonosító)4284 (scopus)85128130388 (wos)000785465100001
Első szerző:Buglyó Gergely (genetikus)
Cím:Liquid Biopsy as a Source of Nucleic Acid Biomarkers in the Diagnosis and Management of Lynch Syndrome / Gergely Buglyó, Jakub Styk, Ondrej Pös, Ádám Csók, Vanda Repiska, Beáta Soltész, Tomas Szemes, Bálint Nagy
Dátum:2022
ISSN:1661-6596 1422-0067
Megjegyzések:Lynch syndrome (LS) is an autosomal dominant inherited cancer predisposition disorder, which may manifest as colorectal cancer (CRC), endometrial cancer (EC) or other malignancies of the gastrointestinal and genitourinary tract as well as the skin and brain. Its genetic cause is a defect in one of the four key DNA mismatch repair (MMR) loci. Testing of patients at risk is currently based on the absence of MMR protein staining and detection of mutations in cancer tissue and the germline, microsatellite instability (MSI) and the hypermethylated state of the MLH1 promoter. If LS is shown to have caused CRC, lifetime follow-up with regular screening (most importantly, colonoscopy) is required. In recent years, DNA and RNA markers extracted from liquid biopsies have found some use in the clinical diagnosis of LS. They have the potential to greatly enhance the efficiency of the follow-up process by making it minimally invasive, reproducible, and time effective. Here, we review markers reported in the literature and their current clinical applications, and we comment on possible future directions.
Tárgyszavak:Orvostudományok Elméleti orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
Lynch syndrome
colorectal cancer
screening
liquid biopsy
circulating nucleic acids
biomarker
Megjelenés:International Journal Of Molecular Sciences. - 23 : 8 (2022), p. 4284. -
További szerzők:Styk, Jakub Pös, Ondrej (1990-) (biológus) Csók Ádám (1994-) (biológus) Repiska Vanda Soltész Beáta (1987-) (molekuláris biológus) Szemes, Tomas (1980-) (biológus) Nagy Bálint (1956-) (molekuláris genetikus)
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

2.

001-es BibID:BIBFORM111719
035-os BibID:(cikkazonosító)8793 (WoS)000996948500001 (Scopus)85160377221
Első szerző:Csók Ádám (biológus)
Cím:Alterations of miRNA Expression in Diffuse Hyperplastic Perilobar Nephroblastomatosis : Mapping the Way to Understanding Wilms' Tumor Development and Differential Diagnosis / Csók Ádám, Micsik Tamás, Magyar Zsófia, Tornóczky Tamás, Kuthi Levente, Nishi Yumika, Szirák Krisztina, Csóka Monika, Ottóffy Gábor, Soltész Beáta, Balogh István, Buglyó Gergely
Dátum:2023
ISSN:1422-0067
Megjegyzések:Wilms' tumor (WT) is the most common renal malignancy in children. In diffuse hyperplastic perilobar nephroblastomatosis (DHPLN), nephrogenic rests result in a bulky enlargement of the kidney, a condition considered as a premalignant state before WT. Despite relevant clinical differences between WT and DHPLN, they are often challenging to distinguish based on histology. Molecular markers would improve differential diagnosis, but none are available at present. In our study, we investigated the potential of microRNAs (miRNAs) as such biomarkers, also aiming to shed light on the chronological order of expression changes. Formalin-fixed, paraffin-embedded (FFPE) samples from four DHPLN cases and adjacent healthy tissues were tested using a PCR array containing primers for 84 miRNAs implicated in genitourinary cancer. Expression in DHPLN was compared to WT data available in dbDEMC. Let-7, miR-135, miR-146a-5p, miR-182-5p, miR-183-5p, miR-20b-3p, miR-29b-3p, miR-195-5p and miR-17-5p showed potential to be used as biomarkers to distinguish WT and DHPLN in cases when traditional differential diagnosis is inconclusive. Our study also revealed miRNAs which may play a role in the initial steps of the pathogenesis (at a precancerous stage) and ones which become deregulated later in WT. More experiments are needed to confirm our observations and find new candidate markers.
Tárgyszavak:Orvostudományok Elméleti orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
Wilms' tumor
nephrogenic rest
diffuse hyperplastic perilobar nephroblastomatosis
miRNA
formalin-fixed, paraffin-embedded sample
Megjelenés:International Journal Of Molecular Sciences. - 24 : 10 (2023), p. 1-16. -
További szerzők:Micsik Tamás Magyar Zsófia Tornóczky Tamás Kuthi Levente Nishi, Yumika Szirák Krisztina (1973-) (molekuláris genetikus) Csóka Mónika Ottóffy Gábor Soltész Beáta (1987-) (molekuláris biológus) Balogh István (1972-) (molekuláris biológus, genetikus) Buglyó Gergely (1980-) (genetikus)
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

3.

001-es BibID:BIBFORM112946
035-os BibID:(cikkazonosító)10520 (WoS)001030973400001 (Scopus)85164844125
Első szerző:Pös, Ondrej (biológus)
Cím:Cross-Kingdom Interaction of miRNAs and Gut Microbiota with Non-Invasive Diagnostic and Therapeutic Implications in Colorectal Cancer / Pös Ondrej, Styk Jakub, Buglyó Gergely, Zeman Michal, Lukyova Lydia, Bernatova Kamila, Hrckova Turnova Evelina, Rendek Tomas, Csók Ádám, Repiska Vanda, Nagy Bálint, Szemes Tomas
Dátum:2023
ISSN:1422-0067
Megjegyzések:Colorectal cancer (CRC) has one of the highest incidences among all types of malignant diseases, affecting millions of people worldwide. It shows slow progression, making it preventable. However, this is not the case due to shortcomings in its diagnostic and management procedure and a lack of effective non-invasive biomarkers for screening. Here, we discuss CRC-associated microRNAs (miRNAs) and gut microbial species with potential as CRC diagnostic and therapy biomarkers. We provide rich evidence of cross-kingdom miRNA-mediated interactions between the host and gut microbiome. miRNAs have emerged with the ability to shape the composition and dynamics of gut microbiota. Intestinal microbes can uptake miRNAs, which in turn influence microbial growth and provide the ability to regulate the abundance of various microbial species. In the context of CRC, targeting miRNAs could aid in manipulating the balance of the microbiota. Our findings suggest the need for correlation analysis between the composition of the gut microbiome and the miRNA expression profile.
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
colorectal cancer
biomarker
gut microbiota
microRNA
Megjelenés:International Journal Of Molecular Sciences. - 24 : 13 (2023), p. 1-21. -
További szerzők:Styk, Jakub Buglyó Gergely (1980-) (genetikus) Zeman, Michal Lukyova, Lydia Bernatova, Kamila Hrckova Turnova, Evelina Rendek, Tomas Csók Ádám (1994-) (biológus) Repiska Vanda Nagy Bálint (1956-) (molekuláris genetikus) Szemes, Tomas (1980-) (biológus)
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

4.

001-es BibID:BIBFORM099574
035-os BibID:(cikkazonosító)8 (scopus)85121366077 (wos)000751087400001
Első szerző:Soltész Beáta (molekuláris biológus)
Cím:The Role of Exosomes in Cancer Progression / Soltész Beáta, Buglyó Gergely, Németh Nikolett, Szilágyi Melinda, Pös Ondrej, Szemes Tomas, Balogh István, Nagy Bálint
Dátum:2022
ISSN:1661-6596 1422-0067
Megjegyzések:Early detection, characterization and monitoring of cancer are possible by using extracellular vesicles (EVs) isolated from non-invasively obtained liquid biopsy samples. They play a role in intercellular communication contributing to cell growth, differentiation and survival, thereby affecting the formation of tumor microenvironments and causing metastases. EVs were discovered more than seventy years ago. They have been tested recently as tools of drug delivery to treat cancer. Here we give a brief review on extracellular vesicles, exosomes, microvesicles and apoptotic bodies. Exosomes play an important role by carrying extracellular nucleic acids (DNA, RNA) in cell-to-cell communication causing tumor and metastasis development. We discuss the role of extracellular vesicles in the pathogenesis of cancer and their practical application in the early diagnosis, follow up, and next-generation treatment of cancer patients.
Tárgyszavak:Orvostudományok Elméleti orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
Megjelenés:International Journal Of Molecular Sciences. - 23 : 1 (2022), p. 1-19. -
További szerzők:Buglyó Gergely (1980-) (genetikus) Németh Nikolett (1995-) (biológus) Szilágyi Melinda (1984-) (biológus) Pös, Ondrej (1990-) (biológus) Szemes, Tomas (1980-) (biológus) Balogh István (1972-) (molekuláris biológus, genetikus) Nagy Bálint (1956-) (molekuláris genetikus)
Pályázati támogatás:Operational Programme Integrated Infrastructure for the project ITMS2014+
Egyéb
313011V446 European Regional Development Fund
Egyéb
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

5.

001-es BibID:bibEBI00026276
035-os BibID:(cikkazonosító)6827 (scopus)85091140313 (wos)000579918800001
Első szerző:Szilágyi Melinda (biológus)
Cím:Circulating cell-free nucleic acids : main characteristics and clinical application / Melinda Szilágyi, Ondrej Pös, Éva Márton, Gergely Buglyó, Beáta Soltész, Judit Keserű, András Penyige, Tomas Szemes, Bálint Nagy
Dátum:2020
ISSN:1661-6596 1422-0067
Megjegyzések:Liquid biopsy recently became a very promising diagnostic method that has several advantages over conventional invasive methods. Liquid biopsy may serve as a source of several important biomarkers including cell-free nucleic acids (cf-NAs). Cf-DNA is widely used in prenatal testing in order to characterize fetal genetic disorders. Analysis of cf-DNA may provide information about the mutation profile of tumor cells, while cell-free non-coding RNAs are promising biomarker candidates in the diagnosis and prognosis of cancer. Many of these markers have the potential to help clinicians in therapy selection and in the follow-up of patients. Thus, cf-NA-based diagnostics represent a new path in personalized medicine. Although several reviews are available in the field, most of them focus on a limited number of cf-NA types. In this review, we give an overview about all known cf-NAs including cf-DNA, cf-mtDNA and cell-free non-coding RNA (miRNA, lncRNA, circRNA, piRNA, YRNA, and vtRNA) by discussing their biogenesis, biological function and potential as biomarker candidates in liquid biopsy. We also outline possible future directions in the field.
Tárgyszavak:Orvostudományok Elméleti orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
cell-free nucleic acids
nDNA
mtDNA
miRNA
lncRNA
circRNA
exosomes
biological fluids
liquid biopsy
Megjelenés:International Journal of Molecular Sciences. - 21 : 18 (2020), p. 1-20. -
További szerzők:Pös, Ondrej (1990-) (biológus) Márton Éva (1992-) (biológus) Buglyó Gergely (1980-) (genetikus) Soltész Beáta (1987-) (molekuláris biológus) Keserű Judit (1976-) (molekuláris genetikus) Penyige András (1954-) (molekuláris genetikus) Szemes, Tomas (1980-) (biológus) Nagy Bálint (1956-) (molekuláris genetikus)
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Rekordok letöltése1